Caroline Samer

Caroline Samer is an Associate Professor at the University of Geneva (UNIGE) Faculty of Medicine and serves as the Head of the Division of Clinical Pharmacology and Toxicology at the Hôpitaux Universitaires de Genève (HUG). She also acts as the Delegate to the Dean's Office for Data Issues since July 2023.

• Medical Degree (2001), PhD in Pharmacogenomics, Postdoctoral Fellowship in Molecular Pharmacology (Sydney)
• President of the Swiss Society for Clinical Pharmacology and Toxicology (SSPTC) and Swiss Society of Pharmacology and Toxicology (SSPT)
• Vice-President of Swissethics and the Geneva Research Ethics Committee (CCER)

Her research focuses on personalizing drug therapy through pharmacogenomics and precision medicine, emphasizing gene-environment-disease interactions and omic technologies. Key themes include drug interactions, pharmacokinetic modeling, and therapeutic information.

Recent publications highlight her work in pharmacogenomics, drug safety, and clinical pharmacology, with a focus on opioids, antiaggregants, and drug metabolism. Her collaborations span oncopediatrics, internal medicine, medical informatics, and pharmaceutical sciences.

She leads the Samer-Daali Research Group, which integrates in vitro, in vivo, and in silico models to advance personalized therapy. Her work is supported by institutional affiliations with the Faculty Center of Translational Investigation in Biomarkers and CIOMS.